. Author manuscript; available in PMC: 2019 Mar 14.

Published in final edited form as: J Alzheimers Dis. 2017;60(2):427–437. doi: 10.3233/JAD-161294

Table 3.

Comparisons of demographic and clinical variables between subjects with baseline CDR Global score of 0 and 0.5

Variables	All sample	Baseline CDR		Baseline CDR 0		Baseline CDR 0.5		Baseline CDR 0		Baseline CDR 0.5
Variables	All sample	0	0.5	Cognitive stable	Cognitive decline	Cognitive stable	Cognitive decline	Non-completers	Completers	Non-completers	Completers
Subject, n	644	497	147	435	62	101	46	186	311	67	80
Age, M (SD)	79.5 (3.6)	79.4 (3.6)	79.8 (3.6)	79.3 (3.6)	80.2 (3.9)	79.3 (3.5)	81.0 (3.6)^*	80.0 (4.2)	79.0 (3.2)^*	80.3 (4.0)	79.4 (3.2)
Male, %	41.8	39.6	49.0^*	40.2	35.5	51.5	43.5	37.1	41.2	55.2	43.8
White, %	77.2	77.3	76.9	79.5	61.3^*	76.2	78.3	71.5	80.7^*	68.7	83.8^*
Married, %	55.9	54.3	61.2	55.2	48.4	63.4	56.5	45.7	59.5^*	68.7	55
Education (y), M (SD)	15.0(3.1)	15.0 (3.0)	14.8 (3.4)	15.2 (2.9)	14.0 (3.4)^*	14.8 (3.5)	14.7 (3.1)	14.5 (3.0)	15.3 (2.9)^*	14.1 (3.6)	15.4 (3.1)^*
Living with study partners, %	49.1	47.5	54.4	46.9	51.6	56.4	50	41.9	50.8	62.7	47.5
Subject’s CFI at baseline	2.4 (2.3)	2.0 (1.9)	3.8 (2.9)^*	1.9 (1.8)	2.7 (2.3)^*	3.4 (2.8)	4.5 (3.1)^*	2.4 (2.1)	1.8 (1.8)^*	4.5 (3.3)	3.2 (2.4)^*
Study partner’s CFI at baseline	1.5 (2.1)	1.0 (0.2)	3.0 (2.9)^*	0.9 (1.4)	1.6 (2.1)^*	2.8 (2.8)	3.5 (2.9)	1.1 (1.6)	1.0 (1.5)	3.6 (3.2)	2.5 (2.5)^*
CDR-SOB, M (SD)	0.3 (0.5)	0.1 (0.2)	1.0 (0.5)^*	0.1 (0.2)	0.2 (0.2)^*	1.0 (0.5)	1.2 (0.5)^*	0.1 (0.2)	0.1 (0.2)	1.2 (0.6)	0.9 (0.5)^*
mMMSE, M (SD)	95.3 (3.7)	95.6 (3.5)	94.1 (3.9)^*	96.1 (3.2)	92.2 (3.8)^*	94.7 (3.9)	92.8 (3.8)^*	94.8 (3.8)	96.1 (3.2)^*	93.0 (4.4)	94.9 (3.3)
FSCRT, M (SD)	47.8 (0.5)	47.8 (0.5)	47.7 (0.7)^*	47.9 (0.4)	47.6 (0.8)^*	47.8 (0.5)	47.5 (0.9)^*	47.8 (0.6)	47.9 (0.4)	47.6 (0.8)	47.8 (0.5)
GDS, M (SD)	1.5 (2.0)	1.3 (1.8)	2.4 (2.4)^*	1.2 (1.8)	1.6 (2.3)	2.3 (2.3)	2.7 (2.7)	1.6 (2.0)	1.1 (1.7)^*	2.9 (2.4)	2.0 (2.4)^*

p ≤ 0.05.